PT - JOURNAL ARTICLE AU - Shohei Okamoto AU - Kazuki Kamimura AU - Kohei Komamura TI - Vaccination or restriction?: COVID-19 vaccine hesitancy and vaccine passports AID - 10.1101/2021.09.15.21263559 DP - 2022 Jan 01 TA - medRxiv PG - 2021.09.15.21263559 4099 - http://medrxiv.org/content/early/2022/01/06/2021.09.15.21263559.short 4100 - http://medrxiv.org/content/early/2022/01/06/2021.09.15.21263559.full AB - Objectives While the development of vaccines against the novel coronavirus (COVID-19) brought the hope of establishing herd immunity, which might help end the global pandemic, vaccine hesitancy can hinder the progress towards herd immunity. In this study, we assess the determinants of vaccine hesitancy, reasons for hesitation, and effectiveness of vaccine passports in relaxing public health restrictions.Methods Through an online survey that includes a conjoint experiment of a demographically representative sample of 5,000 Japanese adults aged 20–74, we assess the determinants of vaccine hesitancy, reasons for hesitation, and effectiveness of hypothetical vaccine passports.Results We found that about 30% of respondents did not intend to vaccinate or have not yet decided, with major reasons for vaccine hesitancy being related to concerns about the safety and side effects of the vaccine. In line with previous findings, younger age, lower socioeconomic status, and psychological factors such as weaker COVID-19 fear were associated with vaccine hesitancy. The easing of public health restrictions such as travel, wearing face masks, and dining out at night was associated with an increase in vaccine acceptance by 4–10%.Conclusion Vaccine hesitancy can be reduced by mitigating the concerns about vaccine safety and side effects, as well as by relaxing public health restrictions. However, the feasibility of vaccine passports needs to be sufficiently assessed, taking the ethical issues of passports and the public health impacts of the relaxation of restrictions into careful consideration.Strengths and limitations of this study□ This study includes timely data on COVID-19 vaccine hesitancy, obtained from a demographically representative sample of 5,000 Japanese adults.□ A conjoint experiment allows assessing the effectiveness of easing public health restrictions on vaccine acceptance.□ Actual behaviour may diverge from the survey responses or fluctuate due to the pandemic situation and the timing of the survey.□ Results may not be applicable in other countries, since the pandemic situation, government responses to the pandemic, and reasons for vaccine hesitancy can vary across countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementShohei Okamoto is supported by a Grant-in-Aid for JSPS Fellows (No. 20J00394) and the Murata Science Foundation. This research was supported in part by financial supports by the Research Centre for Financial Gerontology of Keio University. However, all founders were not involved in conceptualisation, design, data collection, analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board of the Institute of Economics Studies, Keio University (No. 21009R) and all participants provided informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study are not available as we did not obtain the agreement of the participants to make the data open.